FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2144080785> ?p ?o ?g. }

• W2144080785 endingPage "53" @default.
• W2144080785 startingPage "48" @default.
• W2144080785 abstract "Background Many patients with acute ischaemic stroke do not receive intravenous thrombolysis due to contraindications. We aimed to assess safety, short-term clinical development, short-term outcome and mortality in patients treated off-label with tissue plasminogen activator (tPA). Methods Stroke patients treated with tPA within 4.5 h after symptom onset during 2006–2011 were prospectively included. Patients with contraindications to tPA according to national guidelines were compared to patients without any of these contraindications. Separate analyses were performed on patients who had compatible contraindications and did not receive tPA. Primary outcome was rate of symptomatic intracerebral haemorrhage (SICH). Secondary outcomes were short-term clinical development, short-term outcome and 30-day mortality. Results Of the 265 patients who received tPA, 135 patients (50.9%) had formal contraindications and 130 patients (49.1%) had no such contraindications. Rates of SICH were similar for patients with or without contraindications (P = 0.305). Patients with contraindications to tPA had a similar rate of clinical improvement (P = 0.504), a trend of less favourable outcome (P = 0.052) and higher mortality (P = 0.005) than patients without contraindications. Logistic regression analysis showed no association between presence of contraindications to tPA and short-term outcome or mortality when adjusted for age, sex and admission National Institute of Health Stroke Scale score. Short-term outcome and mortality were similar in patients with contraindications who received tPA and patients with contraindications who did not receive tPA (n = 134). Conclusions Intravenous thrombolysis with tPA may be safe and efficient in stroke patients with a number of formal contraindications to tPA. Prospective randomized trials are imperative to clarify the need for a re-evaluation of the current contraindications to tPA." @default.
• W2144080785 created "2016-06-24" @default.
• W2144080785 creator A5011121254 @default.
• W2144080785 creator A5039584991 @default.
• W2144080785 creator A5042469957 @default.
• W2144080785 creator A5058926270 @default.
• W2144080785 creator A5082032094 @default.
• W2144080785 creator A5085853707 @default.
• W2144080785 date "2013-01-11" @default.
• W2144080785 modified "2023-09-23" @default.
• W2144080785 title "Safety of off-label stroke treatment with tissue plasminogen activator" @default.
• W2144080785 cites W1588566741 @default.
• W2144080785 cites W1965854923 @default.
• W2144080785 cites W1969869458 @default.
• W2144080785 cites W1974638135 @default.
• W2144080785 cites W1977858475 @default.
• W2144080785 cites W2013744081 @default.
• W2144080785 cites W2037537497 @default.
• W2144080785 cites W2043407360 @default.
• W2144080785 cites W2065063783 @default.
• W2144080785 cites W2069334904 @default.
• W2144080785 cites W2078148289 @default.
• W2144080785 cites W2084251269 @default.
• W2144080785 cites W2099461303 @default.
• W2144080785 cites W2101970339 @default.
• W2144080785 cites W2109783545 @default.
• W2144080785 cites W2127272421 @default.
• W2144080785 cites W2132397264 @default.
• W2144080785 cites W2134155944 @default.
• W2144080785 cites W2136028603 @default.
• W2144080785 cites W2138595885 @default.
• W2144080785 cites W2139857865 @default.
• W2144080785 cites W2141132646 @default.
• W2144080785 cites W2148909895 @default.
• W2144080785 cites W2159233098 @default.
• W2144080785 doi "https://doi.org/10.1111/ane.12076" @default.
• W2144080785 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23311439" @default.
• W2144080785 hasPublicationYear "2013" @default.
• W2144080785 type Work @default.
• W2144080785 sameAs 2144080785 @default.
• W2144080785 citedByCount "31" @default.
• W2144080785 countsByYear W21440807852014 @default.
• W2144080785 countsByYear W21440807852015 @default.
• W2144080785 countsByYear W21440807852016 @default.
• W2144080785 countsByYear W21440807852017 @default.
• W2144080785 countsByYear W21440807852018 @default.
• W2144080785 countsByYear W21440807852019 @default.
• W2144080785 countsByYear W21440807852020 @default.
• W2144080785 countsByYear W21440807852021 @default.
• W2144080785 countsByYear W21440807852022 @default.
• W2144080785 crossrefType "journal-article" @default.
• W2144080785 hasAuthorship W2144080785A5011121254 @default.
• W2144080785 hasAuthorship W2144080785A5039584991 @default.
• W2144080785 hasAuthorship W2144080785A5042469957 @default.
• W2144080785 hasAuthorship W2144080785A5058926270 @default.
• W2144080785 hasAuthorship W2144080785A5082032094 @default.
• W2144080785 hasAuthorship W2144080785A5085853707 @default.
• W2144080785 hasBestOaLocation W21440807851 @default.
• W2144080785 hasConcept C126322002 @default.
• W2144080785 hasConcept C127413603 @default.
• W2144080785 hasConcept C141071460 @default.
• W2144080785 hasConcept C17624336 @default.
• W2144080785 hasConcept C179755657 @default.
• W2144080785 hasConcept C2776572282 @default.
• W2144080785 hasConcept C2777094939 @default.
• W2144080785 hasConcept C2779581417 @default.
• W2144080785 hasConcept C2780645631 @default.
• W2144080785 hasConcept C2909373784 @default.
• W2144080785 hasConcept C2909817843 @default.
• W2144080785 hasConcept C500558357 @default.
• W2144080785 hasConcept C71924100 @default.
• W2144080785 hasConcept C78519656 @default.
• W2144080785 hasConceptScore W2144080785C126322002 @default.
• W2144080785 hasConceptScore W2144080785C127413603 @default.
• W2144080785 hasConceptScore W2144080785C141071460 @default.
• W2144080785 hasConceptScore W2144080785C17624336 @default.
• W2144080785 hasConceptScore W2144080785C179755657 @default.
• W2144080785 hasConceptScore W2144080785C2776572282 @default.
• W2144080785 hasConceptScore W2144080785C2777094939 @default.
• W2144080785 hasConceptScore W2144080785C2779581417 @default.
• W2144080785 hasConceptScore W2144080785C2780645631 @default.
• W2144080785 hasConceptScore W2144080785C2909373784 @default.
• W2144080785 hasConceptScore W2144080785C2909817843 @default.
• W2144080785 hasConceptScore W2144080785C500558357 @default.
• W2144080785 hasConceptScore W2144080785C71924100 @default.
• W2144080785 hasConceptScore W2144080785C78519656 @default.
• W2144080785 hasIssue "1" @default.
• W2144080785 hasLocation W21440807851 @default.
• W2144080785 hasLocation W21440807852 @default.
• W2144080785 hasOpenAccess W2144080785 @default.
• W2144080785 hasPrimaryLocation W21440807851 @default.
• W2144080785 hasRelatedWork W1980572444 @default.
• W2144080785 hasRelatedWork W2022175645 @default.
• W2144080785 hasRelatedWork W2034433345 @default.
• W2144080785 hasRelatedWork W2077500765 @default.
• W2144080785 hasRelatedWork W2088865135 @default.
• W2144080785 hasRelatedWork W2151714333 @default.
• W2144080785 hasRelatedWork W2999689684 @default.

• next